Denali Therapeutics Inc.
(DNLI)
undefined
undefined%
At close: undefined
22.97
0.04%
After-hours Dec 13, 2024, 04:15 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
PE Ratio | -5.07 | -2.68 | -4.66 | 32.08 | -2.11 | -13.20 | -0.66 | -0.40 | -0.96 |
PS Ratio | 2.23 | 8.05 | 27.85 | 6.80 | 15.61 | 3.70 | 0.00 | 0.00 | 0.00 |
PB Ratio | 0.71 | 0.84 | 1.41 | 1.98 | 1.05 | 0.87 | 0.13 | 0.14 | -1.03 |
P/FCF Ratio | -1.99 | -3.32 | -6.16 | 5.52 | -2.46 | 10.24 | -0.74 | -0.44 | -0.89 |
P/OCF Ratio | -2.06 | -3.57 | -6.41 | 5.48 | -2.75 | 9.55 | -0.76 | -0.48 | -1.07 |
OCF/S Ratio | -0.27 | -0.56 | -1.09 | 0.31 | -1.42 | 0.10 | 0.00 | 0.00 | 0.00 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio | 3.41 | 0.95 | 0.59 | 5.22 | 2.37 | 3.73 | 7.24 | 5.00 | 2.40 |
Current Ratio | 3.41 | 0.94 | 0.59 | 5.22 | 2.37 | 3.67 | 7.23 | 5.00 | 2.40 |
Asset Turnover | 0.29 | 0.07 | 0.03 | 0.21 | 0.05 | 0.20 | 0.00 | 0.00 | 0.00 |
Interest Coverage | 0.00 | -5.77 | 0.00 | 0.00 | -3.50 | 0.00 | -11.53 | 0.00 | -38.25 |
Return on Equity (ROE) | -14.09% | -31.27% | -30.20% | 6.18% | -50.04% | -6.63% | -18.93% | -34.05% | 107.38% |
Return on Assets (ROA) | -12.59% | -22.32% | -20.69% | 4.43% | -35.72% | -5.47% | -18.12% | -31.97% | -45.77% |
Return on Capital (ROIC) | -18.28% | -31.08% | -28.83% | 4.09% | -41.97% | -7.37% | -19.07% | -33.38% | -50.23% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 23.73% | 23.38% | 22.12% | 9.16% | -156.22% | 23.56% | 0.00% | 0.00% | 0.00% |
Net Profit Margin | -10.98% | -75.14% | -149.29% | 5.30% | -185.18% | -7.01% | 0.00% | 0.00% | 0.00% |